Advanced/Metastatic Cancer clinical trials at UCSF

1 in progress, 0 open to eligible people

Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.
Sorry, accepting new patients by invitation only
This is a nonrandomized, open-label, multicenter rollover study for patients who received futibatinib as monotherapy or as combination therapy in a Taiho-sponsored futibatinib study.
San Francisco, California

Last updated: October 30, 2024